Profile data is unavailable for this security.
About the company
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
- Revenue in USD (TTM)52.79bn
- Net income in USD22.98bn
- Incorporated1996
- Employees108.00k
- LocationNovartis AGLichtstrasse 35BASEL 4056SwitzerlandCHE
- Phone+41 613241111
- Fax+41 613247826
- Websitehttps://www.novartis.com/
More ▼
Mergers & acquisitions
Acquired company | NOVN:SWX since announced | Transaction value |
---|---|---|
Gyroscope Therapeutics Holdings PLC(WAS 4L1215) | 2.12% | 1.50bn |
Alnylam Pharmaceuticals Inc | 6.32% | -- |
Arctos Medical AG | 4.96% | -- |
Data delayed at least 15 minutes, as of Aug 11 2022 16:36 BST.